Combining stage specificity and metabolomic profiling to advance antimalarial drug discovery

Authors

James M Murithi, Columbia University
Edward S Owen, The Pennsylvania State University
Eva S Istvan, Washington University School of Medicine in St. Louis
Marcus C S Lee, Wellcome Sanger Institute
Sabine Ottilie, University of California - San Diego
Kelly Chibale, University of Cape Town
Daniel E Goldberg, Washington University School of Medicine in St. Louis
Elizabeth A Winzeler, University of California - San Diego
Manuel Llinás, The Pennsylvania State University
David A Fidock, Columbia University
Manu Vanaerschot, Columbia University

Journal

Cell Chemical Biology

Publication Date

2-20-2020

Volume

27

Issue

2

First Page

158

Last Page

171

Document Type

Open Access Publication

DOI

10.1016/j.chembiol.2019.11.009

Rights and Permissions

Murithi JM, Owen ES, Istvan ES, et al. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery. Cell Chem Biol. 2020;27(2):158-171.e3. doi:10.1016/j.chembiol.2019.11.009 Copyright 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Murithi, James M; Owen, Edward S; Istvan, Eva S; Lee, Marcus C S; Ottilie, Sabine; Chibale, Kelly; Goldberg, Daniel E; Winzeler, Elizabeth A; Llinás, Manuel; Fidock, David A; and Vanaerschot, Manu, "Combining stage specificity and metabolomic profiling to advance antimalarial drug discovery." Cell Chemical Biology. 27, 2. 158 - 171. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9155